| dc.contributor.author | Buckley, Ciara | |
| dc.contributor.author | Treweek, Shaun | |
| dc.contributor.author | Laidlaw, Lynn | |
| dc.contributor.author | Shiely, Frances | |
| dc.date.accessioned | 2023-12-08T00:06:15Z | |
| dc.date.available | 2023-12-08T00:06:15Z | |
| dc.date.issued | 2023-02-07 | |
| dc.identifier | 227699457 | |
| dc.identifier | ca51a571-e462-4432-b1f9-2ff6e3860ff7 | |
| dc.identifier | 36747232 | |
| dc.identifier | 85147460811 | |
| dc.identifier.citation | Buckley , C , Treweek , S , Laidlaw , L & Shiely , F 2023 , ' Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials ' , Trials , vol. 24 , no. 1 , 93 . https://doi.org/10.1186/s13063-022-06980-9 | en |
| dc.identifier.issn | 1745-6215 | |
| dc.identifier.uri | http://aura-test.abdn.ac.uk/handle/2164/20005 | |
| dc.description | Acknowledgements We would like to acknowledge our PPI colleagues on Twitter who read and commented on our work, helping bring the importance of PPI in clinical trials to the fore. Funding There was no direct funding received for this research. The HRB CRF-C at UCC facilitated the placement of an undergraduate BSc Public Health Sciences student, CB, who led this study under supervision. The HRB Clinical Research Facility receives core funding from the Health Research Board, Ireland, and matched funding from University College Cork. The Health Services Research Unit, University of Aberdeen, receives core funding from the Chief Scientist Office of the Scottish Government Health Directorates. | en |
| dc.format.extent | 5 | |
| dc.format.extent | 771257 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Trials | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Trial methodology | en |
| dc.subject | methodology | en |
| dc.subject | Clinical trials | en |
| dc.subject | Patient and Public Involvement/PPI | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials | en |
| dc.type | Journal item | en |
| dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.identifier.doi | https://doi.org/10.1186/s13063-022-06980-9 | |
| dc.identifier.vol | 24 | en |
| dc.identifier.iss | 1 | en |
